AltMountain

Genesis BioCapital Fund I, LP

Chattanooga, TN · CIK 2053141
Emerging

Genesis BioCapital Fund I, LP is a venture capital fund based in Chattanooga, Tennessee. According to its most recent Form D, filed Jan 23, 2026, it has sold $18,480,000 of interests to 21 investors since its first sale in Jan 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Genesis BioCapital Management, LLC; Genesis BioCapital Fund I GP, LP; Ray Tabibiazar.

Total raised
$18,480,000Cumulative sales reported on Form D
Investors
21
First sale
Jan 24, 2025
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Genesis BioCapital Management, LLC; Genesis BioCapital Fund I GP, LP; Ray Tabibiazar
Latest Form D
Jan 23, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Jan 23, 2026Form D/A (amendment)$18,480,00021SEC.gov ↗
Jan 23, 2025Form D$00SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jan 23, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Genesis BioCapital Fund I, LP

What is the minimum investment for Genesis BioCapital Fund I, LP?

Genesis BioCapital Fund I, LP's latest Form D, filed Jan 23, 2026, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Genesis BioCapital Fund I, LP?

Genesis BioCapital Fund I, LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Genesis BioCapital Fund I, LP raised?

Genesis BioCapital Fund I, LP reports $18,480,000 sold from 21 investors on its Form D filed Jan 23, 2026. This is cumulative sales since the offering began, not current assets or performance.

Where is Genesis BioCapital Fund I, LP based?

Genesis BioCapital Fund I, LP is based in Chattanooga, Tennessee.

When did Genesis BioCapital Fund I, LP launch?

Genesis BioCapital Fund I, LP reports its first sale in Jan 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every venture capital fund

Raised more than 73% of the 48 venture capital funds based in Tennessee, and more than 92% of all 14,864 that report sales.

More venture capital funds in Chattanooga

Similar-size venture capital funds in Tennessee

All venture capital funds in Tennessee